1.Study on Numbers of Cervical Cytology before Diagnosis of Cervical Cancer and Cervical Intraepithelial Neoplasia.
Kae Hyun NAM ; Hae Hyeog LEE ; Kwon Dae KIM ; Jin Woo LEE ; Do Hyeong KOO
Korean Journal of Gynecologic Oncology and Colposcopy 2001;12(2):128-136
OBJECTIVE: Although a great deal of knowledge accumulated with regard to the causes and epidemiologic features of cervical cancer, primary prevention has not been particularly effective to date. Most efforts with regards of control of cervical cancer have been directed toward secondary prevention with cytologic smears in a screening program. The purpose of this study was to know the cervical smear histories in the women with neoplasia of uterine cervix at present. MATERIALS AND METHOD: Between June, 1993 and October, 1996, seventy women with invasive cervical carcinoma and eighty-seven women with cervical intraepithelial neoplasia(CIN) were interviewed about cervical smear histories to assess the frequencies of past smear at the Soonchunhyang University Hospital. RESULTS: The results were follows: 1. The mean age of the women with invasive cervical cancer and CIN were 55+/-9 and 42+/-11, respectively. 2. Of the 70 cases of cervical cancer, 61%(43/70) has not been screened, compared with 43%(37/87) in cases of CIN. 3. The mean ages at first smear in the cases of previous smear were 42+/-6 of 27 cancers, 37+/-7 of 50 CINs. The gap between the age at the first smear and the age at diagnosis were about 6 years in cases of cervical cancers, about 5 years in cases of CIN. 4. The most common symptom in cervical cancers was vaginal bleeding or postcoital bleeding(57%). Although 13%(9/70) were discovered during screening without symptom in the women with cervical cancers, 58%(52/87) were diagnosed incidently during screening in CIN. 5. Pap smear numbers before diagnosis were strongly associated with age and stage. Among women diagnosed with invasive cancer under the age of 49, 75% had at least one cervical smear. But, all women with cervical cancer over age of 65 have not been screened. Unscreened rates of stage I, II, III, and IV were 34%, 78%, 85% and 83% respectively. 6. Among 38 cases who had undergone radiation therapy, 82%(31/38) had not been screen in contrast to 38%(12/32) in the women who had undergone radical surgery. 7. Among women with previous smears in the cervical cancer, 20%(14/70) have been screened within 1year. CONCLUSION: It is likely to diagnosis cervical cancer who had normal papanicolau smear in recent. So papanicolau smear is examined carefully and other adjunctive test is help to diagnosis cervical cancer exactly, for example cervicography, HPV testing.
Cervical Intraepithelial Neoplasia*
;
Cervix Uteri
;
Diagnosis*
;
Female
;
Humans
;
Mass Screening
;
Primary Prevention
;
Secondary Prevention
;
Uterine Cervical Neoplasms*
;
Uterine Hemorrhage
;
Vaginal Smears
2.Partial Trisomy 2q(2q37.3->qter)and Monosomy 7q(7q34->qter) Due to Paternal Reciprocal Translocation 2;7: A Case Report.
Yong Ho LEE ; Jun Mo AHN ; Do Hyeong KOO ; Kye Won KWON ; You Kyoung LEE ; Hae Hyeog LEE ; Kye Hyun NAM ; Kwon Hae LEE
Journal of Korean Medical Science 2003;18(1):112-113
We report an unbalanced translocation involving chromosome 2 and 7 due to a balanced reciprocal translocation 2;7 in the father. The female fetus had a partial trisomy of the long arm of chromosome 2 with a partial monosomy of distal 7q. Ultrasound at the first trimester had indicated normal fetal anatomy, including normal intracranial structures. Parental karyotypes showed a paternal balanced translocation: 46,XY,t(2;7)(q37.3;->q34). The unbalanced translocation in the fetus resulted in trisomy for 2q37.3 qter and monosomy for 7q34->qter. Postnatal examination showed that the female abortus had a cleft lip and palate, and mild dysmorphic features. The clinical phenotype was in agreement with previous descriptions and allowed us to propose a fetal phenotype for this chromosomal abnormality.
Abnormalities, Multiple/embryology
;
Abnormalities, Multiple/genetics*
;
Abortion, Habitual/genetics
;
Abortion, Therapeutic
;
Adult
;
Chromosome Disorders/embryology
;
Chromosome Disorders/genetics*
;
Chromosomes, Human, Pair 2/ultrastructure*
;
Chromosomes, Human, Pair 7/ultrastructure*
;
Female
;
Fetal Diseases/genetics
;
Fetal Diseases/pathology
;
Fetus/abnormalities*
;
Human
;
Male
;
Monosomy*
;
Phenotype
;
Pregnancy
;
Translocation (Genetics)*
;
Trisomy*
3.Pneumomediastinum Following Routine Endotracheal Intubation: A case report.
Soon Ho NAM ; Hae Keum KIL ; Ki Beom KIM ; Sung Jin LEE ; Do Hyeong KIM ; Bon Nyeo KOO
Korean Journal of Anesthesiology 2005;48(3):320-323
Tracheobronchial rupture is considered to be a life-threatening condition and most commonly occurs after blunt trauma to the neck or chest. However, single- and double-lumen endotracheal tubes can cause serious airway injury. The recognition of this complication and a knowledge of the possible contributory factors is critical, because failure to do so could result in lethal events. We report the case of a 63-year-old male patient who developed pneumomediastinum three days after routine orotracheal intubation.
Humans
;
Intubation
;
Intubation, Intratracheal*
;
Male
;
Mediastinal Emphysema*
;
Middle Aged
;
Neck
;
Rupture
;
Subcutaneous Emphysema
;
Thorax
4.Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
Ji Won LEE ; Do Hoon LIM ; Ki Woong SUNG ; Hyeong Jin LEE ; Eun Sang YI ; Keon Hee YOO ; Hong Hoe KOO ; Yeon Lim SUH ; Hyung Jin SHIN
Journal of Korean Medical Science 2017;32(2):195-203
With the aim to investigate the outcome of tandem high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) for high-grade gliomas (HGGs), we retrospectively reviewed the medical records of 30 patients with HGGs (16 glioblastomas, 7 anaplastic astrocytomas, and 7 other HGGs) between 2006 and 2015. Gross or near total resection was possible in 11 patients. Front-line treatment after surgery was radiotherapy (RT) in 14 patients and chemotherapy in the remaining 16 patients including 3 patients less than 3 years of age. Eight of 12 patients who remained progression free and 5 of the remaining 18 patients who experienced progression during induction treatment underwent the first HDCT/auto-SCT with carboplatin + thiotepa + etoposide (CTE) regimen and 11 of them proceeded to the second HDCT/auto-SCT with cyclophosphamide + melphalan (CyM) regimen. One patient died from hepatic veno-occlusive disease (VOD) during the second HDCT/auto-SCT; otherwise, toxicities were manageable. Four patients in complete response (CR) and 3 of 7 patients in partial response (PR) or second PR at the first HDCT/auto-SCT remained event free: however, 2 patients with progressive tumor experienced progression again. The probabilities of 3-year overall survival (OS) after the first HDCT/auto-SCT in 11 patients in CR, PR, or second PR was 58.2% ± 16.9%. Tumor status at the first HDCT/auto-SCT was the only significant factor for outcome after HDCT/auto-SCT. There was no difference in survival between glioblastoma and other HGGs. This study suggests that the outcome of HGGs in children and adolescents after HDCT/auto-SCT is encouraging if the patient could achieve CR or PR before HDCT/auto-SCT.
Adolescent*
;
Astrocytoma
;
Brain Neoplasms
;
Carboplatin
;
Child*
;
Cyclophosphamide
;
Drug Therapy*
;
Etoposide
;
Glioblastoma
;
Glioma*
;
Hepatic Veno-Occlusive Disease
;
Humans
;
Medical Records
;
Melphalan
;
Radiotherapy
;
Retrospective Studies
;
Stem Cell Transplantation*
;
Stem Cells*
;
Thiotepa
5.A Case of Endometrial Ossification Treated by Ultrasound-guided Dilatation and Curettage.
Dong Woon LEE ; Hae Hyeog LEE ; Do Hyeong KOO ; Tae Hee KIM ; Ill Goo SHIM ; Kwon Hae LEE ; Kye Hyun NAM ; Im Soon LEE ; Kye Won KWON
Korean Journal of Obstetrics and Gynecology 2003;46(12):2502-2505
The endometrial osseous metaplasia is one of a rare conditions which gynecologist experience clinically. Clinical presentation may include irregular menstration, abnormal uterine bleeding, discharge, dysmenorrhea, pelvic pain, and secondary infertility. However the etiology and treatment about this disease are unclear. Recently, ultrasound-guided management of ectopic bone in uterus was suggested more potentially safer based on reported multi-patients women, a large majority was successfully treated. We have experienced a case of endometrial osseous metaplasia diagnosed and treated by ultrasound-guided dilatation and curettage. Which is presented with a brief review of literatures.
Dilatation and Curettage*
;
Dilatation*
;
Dysmenorrhea
;
Female
;
Humans
;
Infertility
;
Metaplasia
;
Pelvic Pain
;
Uterine Hemorrhage
;
Uterus
6.Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study.
Young Jun CHAI ; Jun Hyun HONG ; Do Hoon KOO ; Hyeong Won YU ; Joon Hyop LEE ; Hyungju KWON ; Su Jin KIM ; June Young CHOI ; Kyu Eun LEE
Annals of Surgical Treatment and Research 2015;89(6):295-299
PURPOSE: Primary thyroid lymphoma (PTL) is a rare disease and it has been investigated in a limited number of studies. The present multicenter study evaluated the clinical features and treatment outcomes of PTL. METHODS: The medical records of patients diagnosed with PTL between 2000 and 2013 in three centers were retrospectively reviewed. RESULTS: The study included 11 men and 27 women with a median age of 63.3 years (range, 42-83 years). The median follow-up was 56.0 months (range, 3-156 months). Of the 38 patients included, 16 had mucosa-associated lymphoid tissue (MALT) lymphoma, six had mixed MALT and diffuse large B-cell lymphoma (DLBCL), and 16 had DLBCL. Thirty-five patients (92.1%) had early stage (stage I/II) disease. Of the 16 MALT lymphoma patients, 14 were treated by surgery, and radiotherapy (RT) or chemotherapy was combined in five patients. Two patients received RT or chemotherapy alone. Of the six mixed MALT and DLBCL patients, three underwent surgery with chemotherapy and three underwent chemotherapy alone, RT alone, or surgery with RT. All of the 16 DLBCL patients received chemotherapy, and surgery and RT was combined in 4 and 1 patients, respectively. The 5-year survival was 100% for MALT lymphoma (7 of 7) and mixed MALT and DLBCL patients (5 of 5) and 87.5% for DLBCL patients (7 of 8). CONCLUSION: Early stage PTL has an excellent prognosis when managed by single or combined treatment modalities. Clinicians should consider PTL in patients with underlying Hashimoto's thyroiditis presenting with an enlarging thyroid mass.
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Lymphoid Tissue
;
Lymphoma*
;
Lymphoma, B-Cell
;
Lymphoma, B-Cell, Marginal Zone
;
Male
;
Medical Records
;
Prognosis
;
Radiotherapy
;
Rare Diseases
;
Retrospective Studies
;
Thyroid Gland*
;
Thyroiditis
7.Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors.
June Koo LEE ; Seock Ah IM ; Daewon LEE ; Ji Yeon KIM ; Yoojoo LIM ; Eunyoung LEE ; Hyeong Gon MOON ; Tae Yong KIM ; Sae Won HAN ; Do Youn OH ; Se Hoon LEE ; Wonshik HAN ; Dong Wan KIM ; Tae You KIM ; Dong Young NOH
Journal of Breast Cancer 2013;16(1):66-71
PURPOSE: Exemestane has shown good efficacy and tolerability in postmenopausal women with hormone receptor-positive metastatic breast cancer. However, clinical outcomes in Korean patients have not yet been reported. METHODS: Data on 112 postmenopausal women with metastatic breast cancer were obtained retrospectively. Clinicopathological characteristics and treatment history were extracted from medical records. All patients received 25 mg exemestane daily until objective disease progression. Progression-free survival (PFS) was the primary endpoint, and secondary endpoints were overall survival (OS), objective response rate (ORR), and clinical benefit rate (CBR=complete response+partial response+stable disease for 6 months). RESULTS: The median age of the subjects was 55 years (range, 28-76 years). Exemestane treatment resulted in a median PFS of 5.7 months (95% confidence interval [CI], 4.4-7.0 months) and median OS of 21.9 months (95% CI, 13.6-30.3 months). ORR was 6.4% and CBR was 46.4% for the 110 patients with evaluable lesions. Symptomatic visceral disease was independently associated with shorter PFS (hazard ratio, 3.611; 95% CI, 1.904-6.848; p<0.001), compared with bone-dominant disease in a multivariate analysis of PFS after adjusting for age, hormone receptor, human epidermal growth factor receptor 2, Ki-67 status, dominant metastasis site, and sensitivity to nonsteroidal aromatase inhibitor (AI) treatment. Sensitivity to previous nonsteroidal AI treatment was not associated with PFS, suggesting no cross-resistance between exemestane and nonsteroidal AIs. CONCLUSION: Exemestane was effective in postmenopausal Korean women with hormone receptor-positive metastatic breast cancer who failed previous nonsteroidal AI treatment.
Androstadienes
;
Aromatase
;
Aromatase Inhibitors
;
Breast
;
Breast Neoplasms
;
Disease Progression
;
Disease-Free Survival
;
Female
;
Humans
;
Medical Records
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Receptor, Epidermal Growth Factor
;
Receptor, erbB-2
;
Retrospective Studies